Guard Therapeutics International AB (publ) (GUARD.ST)
SEK 18.8
(2.73%)
SEK 18.8
(2.73%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -116.04 Million | -102.13 Million | -77.59 Million | -37.96 Million | -60.2 Million | -58.45 Million |
| Net Income | -113.32 Million | -114.92 Million | -81.9 Million | -40.28 Million | -44.28 Million | -86.05 Million |
| Depreciation & Amortization | 15 Thousand | 15 Thousand | 15 Thousand | 161 Thousand | 4.38 Million | 22.51 Million |
| Deferred income taxes | - | -15.61 Thousand | -15.55 Thousand | - | - | - |
| Stock-based compensation | 3.27 Million | 617 Thousand | 552 Thousand | - | - | - |
| Change in working capital | -5.8 Million | 11.97 Million | 3.77 Million | 2.16 Million | -19.68 Million | 5.73 Million |
| Other non-cash items | 3.07 Million | 807 Thousand | 538 Thousand | -6000.00 | -622 Thousand | -655 Thousand |
| Investing Cash Flow | 116.26 Million | -1000.00 | - | 118 Thousand | -73 Thousand | - |
| Investments in PPE | - | - | - | - | -73 Thousand | - |
| Acquisitions | - | - | - | 118 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -779 Thousand | 112.59 Million | 176.3 Million | 74.04 Million | 100.29 Million | 64.8 Million |
| Debt repayment | -668 Thousand | -1.16 Million | -1.31 Million | -746 Thousand | -425.00 | -13 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -111 Thousand | 113.76 Million | 177.61 Million | 74.79 Million | 100.71 Million | 51.8 Million |
| Other Financing Activities | -668 Thousand | -1.16 Million | -1.31 Million | -746 Thousand | -424.57 Thousand | 13 Million |
| Accounts receivables | 288 Thousand | 221 Thousand | -667 Thousand | 692 Thousand | -238 Thousand | 197 Thousand |
| Accounts payables | -6.09 Million | 11.75 Million | 4.43 Million | 1.47 Million | -19.4 Million | 5.53 Million |
| Inventory | 6096.00 | -11.75 Thousand | -4439.00 | -1471.00 | - | - |
| Other working capital | -6096.00 | 11.75 Thousand | 4439.00 | 1471.00 | -43 Thousand | 5.53 Million |
| Cash at beginning of period | 201 Million | 188.6 Million | 90.04 Million | 53.83 Million | 13.95 Million | 7.61 Million |
| Cash at end of period | 83.74 Million | 201 Million | 188.6 Million | 90.04 Million | 53.97 Million | 13.95 Million |
| Capital Expenditure | - | - | - | - | -73 Thousand | - |
| Effect of forex changes on cash | 443 Thousand | 1.94 Million | -148 Thousand | - | - | - |
| Net cash flow / Change in cash | -117.26 Million | 12.4 Million | 98.56 Million | 36.2 Million | 40.01 Million | 6.34 Million |
| Free Cash Flow | -116.04 Million | -102.13 Million | -77.59 Million | -37.96 Million | -60.28 Million | -58.45 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -23.87 Million | -14.5 Million | -113.32 Million | -17.09 Million | -24.44 Million | -34.67 Million |
| Depreciation & Amortization | - | - | 15 Thousand | 15.00 | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 3.27 Million | 3270.00 | - | - |
| Change in working capital | 4.36 Million | -3.16 Million | -5.8 Million | -2.99 Million | -2.88 Million | -4.89 Million |
| Other non-cash items | -3.17 Million | 1.44 Million | 3.07 Million | 2.75 Million | 1.48 Million | 1.35 Million |
| Investing Cash Flow | - | - | 116.26 Million | 18.54 Million | - | -1000.00 |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 45.36 Million | -1.7 Million | -779 Thousand | 3000.00 | 355 Thousand | -87 Thousand |
| Debt repayment | -602 Thousand | -1701.00 | -668 Thousand | -668 Thousand | -710.00 | -87.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 45.06 Million | - | -111 Thousand | -111 Thousand | - | - |
| Other Financing Activities | 301 Thousand | -1.7 Million | -668 Thousand | 782 Thousand | 355 Thousand | -86.91 Thousand |
| Accounts receivables | 79 Thousand | 170 Thousand | 288 Thousand | 288 Thousand | 385 Thousand | 127 Thousand |
| Accounts payables | 4.28 Million | -3.33 Million | -6.09 Million | -3.28 Million | -3.26 Million | -5.02 Million |
| Inventory | - | - | 6096.00 | 3362.00 | - | 5021.00 |
| Other working capital | 4.28 Million | -3330.00 | -6096.00 | -3362.00 | -1000.00 | -5021.00 |
| Cash at beginning of period | 65.08 Million | 83.74 Million | 201 Million | 103.19 Million | 128.25 Million | 165.38 Million |
| Cash at end of period | 91.58 Million | 65.08 Million | 83.74 Million | 83.74 Million | 103.19 Million | 128.25 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -541 Thousand | 2.42 Million | 443 Thousand | -1.24 Million | 438 Thousand | 1.17 Million |
| Net cash flow / Change in cash | 26.5 Million | -18.65 Million | -117.26 Million | -19.45 Million | -25.05 Million | -37.13 Million |
| Free Cash Flow | -18.32 Million | -19.37 Million | -116.04 Million | -17.33 Million | -25.85 Million | -38.21 Million |
044380
GAM-PB
102710
VIN
601208
BNK